Summary

The global bubble tea market is experiencing significant growth, driven by the increasing popularity of this unique beverage. Known for its combination of tea, milk, and chewy tapioca pearls or other toppings, bubble tea has become a favorite among consumers worldwide. The market is witnessing a steady rise in demand as more people explore its diverse flavors and customizable options. In 2024, the market is projected to reach a value of approximately USD 1.70 billion, and it is expected to continue expanding at a CAGR of 8.60%, reaching around USD 3.03 billion by 2031.

Regional Insights: South Asia and Pacific Leading the Charge

The South Asia and Pacific region is emerging as a dominant force in the global bubble tea market. The region's cultural affinity for tea, coupled with the growing popularity of cafés and quick-service restaurants, is propelling the demand for bubble tea. This region is projected to hold a substantial share of the global market, indicating strong growth potential in the coming years.

Market Overview: A Small but Growing Segment of the Ready-to-Drink Tea Market

Although bubble tea currently represents a modest portion of the global ready-to-drink tea market, its growth trajectory is impressive. The market has been expanding steadily, with a noticeable surge in consumer interest. This trend is expected to continue, driven by the beverage's unique appeal and the increasing awareness of its health benefits.

Historical and Future Market Trends: Steady Growth in Demand

The bubble tea market has shown consistent growth over recent years, with consumer demand steadily increasing. This upward trend is expected to continue, with the market poised for significant expansion. The growing popularity of pearl milk tea, a variant of bubble tea, is contributing to this demand surge. Consumers are increasingly seeking beverages made with natural ingredients and unique flavors, driving the market's growth.

Factors Driving the Demand for Bubble Tea

Healthy Ingredients and Customization:

The shift in consumer preferences towards healthier beverages is a major factor driving the demand for bubble tea. Manufacturers are focusing on using fresh, natural ingredients such as fruits, organic cream, and soy milk to enhance the nutritional content, flavor, and texture of the drink. This focus on health-conscious ingredients is resonating with consumers, contributing to the beverage's popularity.

Health Benefits:

Bubble tea is more than just a tasty treat; it offers various health benefits. The inclusion of milk, for instance, adds nutritional value, providing calcium for strong bones. The carbohydrates in bubble tea serve as a primary energy source, supporting brain function, heart health, and the central nervous system. Additionally, the drink's antioxidant properties help boost the immune system and protect against oxidative stress.

Stress Relief and Mental Health:

The relaxing properties of bubble tea, combined with its caffeine content, make it an ideal beverage for busy professionals. The drink helps alleviate muscle tension, making it easier to handle daily stress. Moreover, the caffeine in bubble tea enhances memory and cognitive function, providing a mental boost that many find beneficial.

Natural Sweeteners:

As consumers become more health-conscious, there is a growing trend towards using natural sweeteners in bubble tea. Sugar substitutes such as stevia, agave, and honey are gaining popularity as healthier alternatives to traditional sugar. This shift is particularly appealing to those with health concerns such as diabetes, further driving the market's growth.

The Rise of Cafés and Quick Service Restaurants

Café Culture and Bubble Tea:

The expanding café culture, particularly in Asia, is playing a crucial role in the increasing demand for bubble tea. The introduction of bubble tea into café menus has been met with enthusiasm, especially among younger consumers. The convenience, unique flavors, and personalized options offered by bubble tea make it a perfect fit for café culture.

Growth of Quick Service Restaurants:

Quick service restaurants are also contributing to the bubble tea boom. As these establishments expand, particularly in emerging markets, they are introducing bubble tea to a broader audience. This trend is expected to continue, with bubble tea becoming a staple offering in many quick-service restaurants worldwide.

Cost Efficiency:

One of the reasons for bubble tea's widespread popularity is its cost-effectiveness. The ingredients required to make bubble tea, such as tapioca pearls and tea leaves, are relatively inexpensive when purchased in bulk. This allows businesses to offer bubble tea at competitive prices, further boosting its appeal to consumers.

Innovation and Flavor Diversity

Appealing to Millennials:

Manufacturers are keen to tap into the millennial market by introducing innovative bubble tea flavors. This generation is known for its willingness to experiment with new tastes, making them a prime target for creative beverage offerings. Flavors such as apple, dry fruits, and various milk-based options are being introduced to cater to this adventurous demographic.

Health-Conscious Innovations:

As part of their innovation efforts, companies are also focusing on healthier versions of bubble tea. By reducing sugar content or using alternatives like brown sugar and natural flavoring syrups, manufacturers are addressing the health concerns associated with the drink. However, it is important to note that even healthier versions of bubble tea should be consumed in moderation.

Expanding into New Markets:

The potential for growth in untapped markets is significant. Companies are actively exploring opportunities to introduce bubble tea to new regions, focusing on premium products to attract consumers. By establishing a presence in emerging markets, bubble tea manufacturers can capitalize on the growing global demand.

Challenges in the Bubble Tea Market

Health Concerns:

Despite its popularity, bubble tea faces certain challenges, particularly concerning its high sugar content. Consumers are becoming more aware of the negative health impacts of excessive sugar consumption, such as diabetes and obesity. As a result, there is a growing preference for healthier beverage options, which could limit the growth of the bubble tea market.

Caloric Content:

Bubble tea is known for its high calorie content, with a single serving containing a significant amount of sugar and carbohydrates. While this makes it a satisfying treat, it also raises concerns about its suitability as a regular beverage choice. Health experts have warned that frequent consumption of high-calorie drinks like bubble tea can lead to various health issues, potentially hindering the market's expansion.

Shift Towards Organic Beverages:

The presence of artificial preservatives in some bubble tea variants is another concern for health-conscious consumers. This has led to a shift towards organic beverages, which are perceived as healthier and more natural. As a result, some consumers may opt for organic alternatives, affecting the overall demand for bubble tea.

Regional Market Insights

United Kingdom:

In Europe, the United Kingdom stands out as a major market for bubble tea. The country's consumers are known for their enthusiasm for trying new beverages, making it a key market for bubble tea manufacturers. The market in the U.K. is expected to continue growing, driven by the country's vibrant café culture and the increasing popularity of unique, innovative drinks.

Brazil:

In Latin America, Brazil is emerging as a key market for bubble tea. The growing awareness of bubble tea and its unique offerings is driving demand in the country. As more consumers discover bubble tea, the market in Brazil is expected to expand rapidly, offering significant growth opportunities for manufacturers.

Popular Bubble Tea Toppings

Tapioca Pearls:

Tapioca pearls remain the most popular topping for bubble tea, holding the largest market share. However, other toppings such as popping boba and jellies are gaining traction, thanks to their innovative flavors and textures. These options are expected to boost overall sales of bubble tea, as consumers seek out new and exciting ways to enjoy the beverage.

Distribution Channels: Business to Consumer Sales on the Rise

Ready-to-Drink Options:

The business-to-consumer segment of the bubble tea market is showing strong growth, driven by the increasing popularity of ready-to-drink bubble tea and instant mix kits. As consumers seek convenient beverage options, this segment is expected to continue its upward trajectory, providing lucrative opportunities for manufacturers.

Competitive Landscape

Leading bubble tea manufacturers are focused on expanding their market presence by entering new markets and introducing innovative products. This strategy allows companies to gain a competitive edge and establish multiple revenue streams.

Key companies profiled

• Bobble Bobble

• Yen Chuan International Co., Ltd

• Gong Cha USA

• Empire Eagle Food Co., Ltd.

• Quickly Corporation

• Boba Guys, Inc.

• Chatime

• 8tea5

• Kung Fu Tea

• Ten Ren Tea, Inc.

• Tapioca Express, Inc.

• Boise Boba

• Woop Bubble Tea

• Coco Tea

• Sharetea

• BobaTea Factory

• Possmei international Co., Ltd

• Bubble Tea House Company

• The Inspire Food Company

• TACHUNGHO

Bubble Tea Industry Survey by Category

Bubble Tea Market by Base Ingredient:

• Black Tea

• Green Tea

• Oolong Tea

• White Tea

Bubble Tea Market by Flavor:

• Unflavored Bubble Tea

• Flavored Bubble Tea

o Taro

o Coffee

o Fruit Flavors

o Others

Bubble Tea Market by Format:

• Ready-to-Drink Bubble Tea

• Instant Bubble Tea Mix Kits

Bubble Tea Market Topping:

• Tapioca Pearls

• Popping Boba

• Jellies

• Others

Bubble Tea Market by Distribution Channel:

• Business to Business Sales of Bubble Tea

• Business to Consumer Sales of Bubble Tea

o Hypermarkets/Supermarkets

o Convenience Stores

o Online Retail

Bubble Tea Market by Region:

• North America Bubble Tea Market

• Latin America Bubble Tea Market

• Europe Bubble Tea Market

• South Asia and Pacific Bubble Tea Market

• East Asia Bubble Tea Market

• The Middle East and Africa Bubble Tea Market

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Bubble Tea Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Bubble Tea Market Outlook, 2019 - 2031
3.1. Global Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Monotherapy
3.1.1.1.1. Pirfenidone Therapy
3.1.1.1.2. Nintedanib Therapy
3.1.1.1.3. Corticosteroids Therapy
3.1.1.1.4. Combination Therapy
3.1.1.1.5. Pirfenidone & Corticosteroid
3.1.1.1.6. Nintedanib & Corticosteroid
3.1.1.1.7. Pirfenidone & Antitussive
3.1.1.1.8. Others
3.1.1.2. Symptomatic Treatment
3.2. Global Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
3.2.1.2. Familial PF
3.2.1.3. Others
3.3. Global Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacy
3.3.1.2. Retail Pharmacy
3.3.1.3. Mail Order Pharmacy
3.4. Global Bubble Tea Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Bubble Tea Market Outlook, 2019 - 2031
4.1. North America Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Monotherapy
4.1.1.1.1. Pirfenidone Therapy
4.1.1.1.2. Nintedanib Therapy
4.1.1.1.3. Corticosteroids Therapy
4.1.1.1.4. Combination Therapy
4.1.1.1.5. Pirfenidone & Corticosteroid
4.1.1.1.6. Nintedanib & Corticosteroid
4.1.1.1.7. Pirfenidone & Antitussive
4.1.1.1.8. Others
4.1.1.2. Symptomatic Treatment
4.2. North America Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
4.2.1.2. Familial PF
4.2.1.3. Others
4.3. North America Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacy
4.3.1.2. Retail Pharmacy
4.3.1.3. Mail Order Pharmacy
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
4.4.1.2. U.S. Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.3. U.S. Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.1.4. Canada Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
4.4.1.5. Canada Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.6. Canada Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Bubble Tea Market Outlook, 2019 - 2031
5.1. Europe Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Monotherapy
5.1.1.1.1. Pirfenidone Therapy
5.1.1.1.2. Nintedanib Therapy
5.1.1.1.3. Corticosteroids Therapy
5.1.1.1.4. Combination Therapy
5.1.1.1.5. Pirfenidone & Corticosteroid
5.1.1.1.6. Nintedanib & Corticosteroid
5.1.1.1.7. Pirfenidone & Antitussive
5.1.1.1.8. Others
5.1.1.2. Symptomatic Treatment
5.2. Europe Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
5.2.1.2. Familial PF
5.2.1.3. Others
5.3. Europe Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacy
5.3.1.2. Retail Pharmacy
5.3.1.3. Mail Order Pharmacy
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.2. Germany Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.3. Germany Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.4. U.K. Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.5. U.K. Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.6. U.K. Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.7. France Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.8. France Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.9. France Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.10. Italy Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.11. Italy Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.12. Italy Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.13. Turkey Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.14. Turkey Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.15. Turkey Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.16. Russia Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.17. Russia Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.18. Russia Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.19. Rest of Europe Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.20. Rest of Europe Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.21. Rest of Europe Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cassava Starch Market Outlook, 2019 - 2031
6.1. Asia Pacific Cassava Starch Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Monotherapy
6.1.1.1.1. Pirfenidone Therapy
6.1.1.1.2. Nintedanib Therapy
6.1.1.1.3. Corticosteroids Therapy
6.1.1.1.4. Combination Therapy
6.1.1.1.5. Pirfenidone & Corticosteroid
6.1.1.1.6. Nintedanib & Corticosteroid
6.1.1.1.7. Pirfenidone & Antitussive
6.1.1.1.8. Others
6.1.1.2. Symptomatic Treatment
6.2. Asia Pacific Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
6.2.1.2. Familial PF
6.2.1.3. Others
6.3. Asia Pacific Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacy
6.3.1.2. Retail Pharmacy
6.3.1.3. Mail Order Pharmacy
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.2. China Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.3. China Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.4. Japan Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.5. Japan Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.6. Japan Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.7. South Korea Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.8. South Korea Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.9. South Korea Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.10. India Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.11. India Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.12. India Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.13. Southeast Asia Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.14. Southeast Asia Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.15. Southeast Asia Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Bubble Tea Market Outlook, 2019 - 2031
7.1. Latin America Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Monotherapy
7.1.1.1.1. Pirfenidone Therapy
7.1.1.1.2. Nintedanib Therapy
7.1.1.1.3. Corticosteroids Therapy
7.1.1.1.4. Combination Therapy
7.1.1.1.5. Pirfenidone & Corticosteroid
7.1.1.1.6. Nintedanib & Corticosteroid
7.1.1.1.7. Pirfenidone & Antitussive
7.1.1.1.8. Others
7.1.1.2. Symptomatic Treatment
7.2. Latin America Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
7.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
7.2.1.2. Familial PF
7.2.1.3. Others
7.3. Latin America Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacy
7.3.1.2. Retail Pharmacy
7.3.1.3. Mail Order Pharmacy
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.2. Brazil Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.3. Brazil Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.4. Mexico Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.5. Mexico Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.6. Mexico Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.7. Argentina Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.8. Argentina Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.9. Argentina Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.10. Rest of Latin America Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.11. Rest of Latin America Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.12. Rest of Latin America Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Bubble Tea Market Outlook, 2019 - 2031
8.1. Middle East & Africa Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Monotherapy
8.1.1.1.1. Pirfenidone Therapy
8.1.1.1.2. Nintedanib Therapy
8.1.1.1.3. Corticosteroids Therapy
8.1.1.1.4. Combination Therapy
8.1.1.1.5. Pirfenidone & Corticosteroid
8.1.1.1.6. Nintedanib & Corticosteroid
8.1.1.1.7. Pirfenidone & Antitussive
8.1.1.1.8. Others
8.1.1.2. Symptomatic Treatment
8.2. Middle East & Africa Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
8.2.1.2. Familial PF
8.2.1.3. Others
8.3. Middle East & Africa Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.3.1.1. Hospital Pharmacy
8.3.1.2. Retail Pharmacy
8.3.1.3. Mail Order Pharmacy
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.2. GCC Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.3. GCC Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.4. South Africa Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.5. South Africa Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.6. South Africa Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.7. Egypt Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.8. Egypt Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.9. Egypt Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.10. Nigeria Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.11. Nigeria Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.12. Nigeria Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. F. Hoffman - La Roche Ltd.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Boehringer Ingelheim
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. International GmbH
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Cipla Ltd (Cipla)
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Gilead Sciences, Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Bristol-Myers Squibb Company
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. FibroGen Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Galecto, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations